Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Grifols S.A.
DescriptionAntihemophilic factor/von Willebrand factor (vWF) complex
Molecular Target Factor VIII
Mechanism of ActionFactor VIII replacement
Therapeutic ModalityBiologic

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today